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Thousands of DNA lesions are estimated to occur in each cell every day and almost all are
recognized and repaired. DNA repair is an essential system that prevents accumulation
of mutations which can lead to serious cellular malfunctions. Phenotypic evaluation of
DNA repair activity of individuals is a relatively new approach. Methods to assess base
and nucleotide excision repair pathways (BER and NER) in peripheral blood cells based
on modified comet assay protocols have been widely applied in human epidemiological
studies. These provided some interesting observations of individual DNA repair activity
being suppressed among cancer patients. However, extension of these results to cancer
target tissues requires a different approach. Here we describe the evaluation of BER and
NER activities in extracts from deep-frozen colon biopsies using an upgraded version of
the in vitro comet-based DNA repair assay in which 12 reactions on one microscope
slide can be performed. The aim of this report is to provide a detailed, easy-to-follow
protocol together with results of optimization experiments. Additionally, results obtained
by functional assays were analyzed in the context of other cellular biomarkers, namely
single nucleotide polymorphisms and gene expressions. We have shown that measuring
DNA repair activity is not easily replaceable by genomic or transcriptomic approaches, but
should be applied with the latter techniques in a complementary manner. The ability to
measure DNA repair directly in cancer target tissues might finally answer questions about
the tissue-specificity of DNA repair processes and their real involvement in the process of
carcinogenesis.
Keywords: in vitro comet-based DNA repair assay, base excision repair, nucleotide excision repair, human solid
tissue, methodological report
INTRODUCTION
The ability of cells to protect against a large variety of DNA
disruptions is a vital process for living organisms. Base exci-
sion repair (BER) and nucleotide excision repair (NER) belong
to the subgroup of DNA repair mechanisms that are active on
structurally modified DNA bases. The biological significance of
both pathways is highlighted by the well-known association of
BER or NER deficiency with the incidence of inherited (Cleaver
et al., 2009) and sporadic types of cancer (Slyskova et al., 2012a).
Moreover, the individual’s BER and NER capacity is expected to
have an influence on the response to anti-neoplastic drug treat-
ment (Pallis and Karamouzis, 2010; Lord and Ashworth, 2012).
Therefore, being able to screen an individual’s repair capacity may
represent a step toward risk assessment and individualized cancer
therapy.
Our current knowledge of DNA repair indicates that this pro-
cess involves many genes that have to work in a synchronized and
coordinated way. The simultaneous participation of other pro-
cesses such as DNA damage signaling, cell cycle controls, and
maybe even other (un)known genes, makes DNA repair a multi-
gene and multipathway process. There is a body of evidence
concerning different levels of DNA repair gene regulation. The
majority of DNA repair genes are polymorphic in the human
population, with as yet uncharacterized functional consequences
(Ricceri et al., 2012). Therefore, DNA sequence analyses cannot
be sufficiently informative for predicting DNA repair activity.
Gene expression has been shown to be a misleading source of
information, because changes in mRNA levels do not necessarily
reflect changes in enzyme activity and vice versa (Damia et al.,
1998; Vogel et al., 2000; Paz-Elizur et al., 2007; Stevens et al.,
2008; Hanova et al., 2011; Slyskova et al., 2012a,b). This is due
to extensive post-transcriptional and post-translational modifica-
tions and protein–protein interactions that take part in regulating
the activity of repair proteins (Fan and Wilson, 2005; Hu and
Gatti, 2011; Nouspikel, 2011). Moreover, DNA repair is a mul-
tifactorial process that is modulated not exclusively by genetic
background, but, to a certain extent, might be regulated by envi-
ronmental and lifestyle factors (Wu et al., 2006; Collins et al.,
2012). Measuring the true phenotypic endpoint seems in this
context to be the most informative, straightforward, and per-
haps the most reliable way of characterizing the DNA repair
processes.
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Both excision pathways follow a common pattern: recognition
of the DNA lesion, excision of the damage, and resynthesis of
the removed sequence. Transient strand breaks (SBs) are gener-
ated as intermediates during both repair pathways, which make
BER and NER easily measurable on the functional level by meth-
ods based on the comet assay. This assay is a sensitive technique
for quantification of SBs in DNA which is applicable not only to
measure basal DNA damage, but also in a modified form for mea-
suring DNA repair incision activity. So far, human blood has been
used in the majority of studies examining DNA repair activity,
since blood is usually the only tissue that can be sampled from
healthy subjects. Methods for evaluation of BER and NER from
peripheral blood cells are currently well-established (Collins et al.,
2001; Langie et al., 2006). However, often it is important to con-
sider the level of DNA repair in particular organs, especially when
analysing DNA repair activity in association with tissue-specific
diseases. Although it might be logistically complicated in most
cases, from cancer patients, there is still a possibility to obtain
not only peripheral blood, but also surgically resected normal or
tumor tissue. Langie et al. (2010, 2011) have published protocols
modified for assessment of DNA repair activity in animal solid
tissues; however, a methodological approach for its evaluation in
human biopsies has not yet been optimized. Moreover, despite
the undeniable biological significance of DNA repair, DNA repair
activity is still not routinely included as a biomarker in human
biomonitoring studies. This is partially due to the fact that it is
a relatively laborious method, especially when large numbers of
samples are analyzed.
This text presents a detailed comet assay-based protocol for
measuring BER- and NER-specific incision activity in vitro from
deep-frozen human solid tissues, covering all its optimization
steps. The protocol has been recently applied for the first time
on colorectal cancer biopsies (Slyskova et al., 2012b). In order
to increase the applicability of this approach to large-scale epi-
demiological studies, the 12-minigel format (12 agarose minigels
per microscopic slide) instead of the conventional format (one or
two large agarose gels per slide) has been applied. In addition,
the relationship between the detected DNA repair activity and
other biomarkers (single nucleotide variants in and expression of
DNA repair genes) routinely measured in human biomonitoring
studies is also discussed.
MATERIALS AND METHODS
STUDY POPULATION AND COLLECTION OF BIOLOGICAL SPECIMEN
The study was conducted on colorectal tissues collected from 70
CRC patients at the surgical resection of the tumor. Patients were
recruited between 2009 and 2011 in Thomayer Hospital (Prague),
General University Hospital (Prague), and Teaching Hospital and
Medical School of Charles University (Pilsen). All patients gave
informed consent. Ethics approval was granted by appropriate
committees of the three hospitals. The group of patients included
53 men and 17 women with a mean age of 66.2 ± 10.6 years.
The clinical stage of patients at diagnosis was classified accord-
ing to the tumor-node-metastasis (TNM) system. Seven patients
were diagnosed with TNM stage I (10%), 29 as stage II (41.4%),
15 as stage III (21.4%), and 19 as stage IV (27.2%). All patients
had adenocarcinomas; 44 patients had tumor localized in the
colon (62.9%) and 26 in the rectum (37.1%). In 12 (17.2%)
patients, tumors were of well-differentiated grade, in 47 (67.1%)
moderately differentiated and in 11 patients (15.7%) poorly
differentiated. Eleven rectal cancer patients (15.7%) received
neoadjuvant therapy prior to surgery. Tumor tissue and adjacent
healthy colon/rectal tissue (5–10 cm distant from the tumor) were
resected from all patients. Colon biopsies were briefly washed in
PBS and snap frozen immediately after the resection and further
stored at −80◦C. Prior to tissue processing, histological analysis
was carried out to assess the proportion of tumor cells in tumor
tissues and to rule out the presence of neoplastic cells in the nor-
mal mucosal tissues. The cut-off point was set to 80% of tumor
or normal cells in the sample, respectively. Samples were embed-
ded in optimal cutting temperature compound (Sakura Finetek),
and cut with a Leica CM 1850 cryostat. Five µm thick serial sec-
tions were fixed in 90% ethanol on microscope slides and stained
with 1% cresyl violet acetate (Sigma-Aldrich), dehydrated with
ethanol, dried, and inspected using a Leica DM6000 microscope
(Leica). Due to various logistical reasons, not all patients could be
analyzed for all the studied parameters. Therefore, each particular
analysis is further specified for actual number of cases for whom
analysis was carried out.
IN VITRO COMET-BASED DNA REPAIR ASSAY
Principle of the assay
Protein extracts isolated from human tissues were incubated with
substrate DNA in the form of nucleoids, containing artificially
induced lesions known to be repaired specifically by either the
BER or NER pathway. The photosensitizer Ro 19-8022, in the
interaction with visible light, gives rise to oxidative DNA damage
(predominantly to 8-oxoguanines; 8-oxoG) that are specifically
recognized by the BER machinery. Alternatively, nucleoids con-
taining ultraviolet light (UV)-induced cyclobutane pyrimidine
dimers (CPD) and 6-4 photoproducts represent the substrate for
the NER pathway. The level of induced lesions can be detected
by enzymes of bacterial or viral origin, which serve as positive
controls in each experiment. Two types of enzymes were used,
formamidopyrimidine DNA glycosylase (Fpg) as a prokaryotic
analog of human OGG1 that recognizes oxidized purines, and T4
Endonuclease V (Endo V) produced by T4 bacteriophage, recog-
nizing UV-induced CPD. In addition, each experiment included a
negative control, namely lesion-containing substrate DNA incu-
bated with reaction buffer to assess the background damage
together with buffer-induced damage. Furthermore, each protein
extract was measured for (i) specific repair activity (i.e., extract
incubated with lesion-containing DNA) and (ii) non-specific
endonuclease activity (i.e., specificity control; extract incubated
with lesion-free DNA). To be able to record only specific activity
of repair proteins, the non-specific endonuclease activity of the
protein extract was subtracted. The frequency of DNA SBs, gen-
erated during incision of lesions, reflects the DNA repair activity
of the extract.
Substrate DNA
In this protocol, the cellular source of substrate DNA consisted
of peripheral blood mononuclear cells (PBMC) and human-
derived lymphoblastoid cells (TK6), though in principle any
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other mammalian cells in suspension could be used. Cells should
be controlled for low basal level of SBs (ideally not higher
than 10% DNA in tail) and such was the case in this study.
PBMC were separated on Histopaque-1077 (Sigma-Aldrich),
counted, evaluated by trypan blue exclusion and suspended in
ice-cold PBS. TK6 cells were grown in RPMI medium supple-
mented with 10% heat-inactivated fetal calf serum, 0.2mg/mL
sodium pyruvate, 2mM L-glutamine, 100U/mL penicillin, and
0.1mg/mL streptomycin (Sigma-Aldrich). Cells were counted
and suspended in ice-cold PBS. For BER, PBMC were treated
with 2µM Ro 19-8022 (Hoffmann-La Roche) for 5min, and
irradiated on ice at 33 cm distance from a 500W halogen
lamp. For NER, TK6 cells were irradiated with 5 Jm−2 of
UVC (50 s at 0.1 Jm−2s−1). Lesion-free PBMC and TK6 cells
were prepared in parallel. Cells were aliquoted at 5 × 105 in
0.5mL of freezing medium (RPMI 1640, 20% fetal bovine
serum, 0.2% antibiotics, 10% DMSO, Sigma-Aldrich) and frozen
slowly to −80◦C. Before each experiment, cells were thawed
by adding 1mL of cold PBS, spun at 400 g, 5min, 4◦C,
and suspended in 400µL of PBS. An 80µL aliquot of the
cell extract was mixed with 260µL of 1% LMP agarose to
reach the desired concentration of cells (∼300–600 cells per
minigel). Using a multi-dispensing pipette, twelve 5µL minigels
of cells in agarose were placed on each microscope slide. Cells
embedded in agarose underwent lysis for 1 h in 2.5M NaCl,
100mM EDTA, 10mM Tris, 250mM NaOH, 1% Triton X-
100, pH 10. Before incubation with protein extracts, slides were
washed twice for 5min with buffer B (45mM HEPES, 0.25mM
EDTA, 0.3mg/mL BSA, 2% glycerol, pH 7.8) and placed in
incubation chambers (Severn Biotech) (Shaposhnikov et al.,
2010).
Protein extracts preparation
Tissue resections were weighed and ground while frozen, and 30–
50mg aliquots were stored at −80◦C. For extraction, a volume
of 100µL of buffer A (45mM HEPES, 0.4M KCl, 1mM EDTA,
0.1mM DTT, 10% glycerol, pH 7.8) was added to every 50mg of
ground tissue. Samples were vortexed, snap frozen, and 30µL of
1% Triton X-100 in buffer A added per 100µL. Protein concen-
tration was measured by a fluorescamine assay (Sigma-Aldrich),
on a NanoDrop 3300 (Thermo Scientific). Undiluted extracts
were kept at −80◦C. Before the incubation reaction, on the day of
use, extracts were diluted to a protein concentration of 3mg/mL
in buffer A in a final volume of 50µL and mixed with 4 volumes
of buffer B.
BER-specific reaction
A 30µL aliquot of extract was added to each minigel in the incu-
bation chamber. Each extract was incubated with Ro-treated as
well as non-treated PBMC (used for background subtraction).
Incubation time was 20min, at 37◦C in a humid environment.
Fpg was used as a positive control. For a negative control substrate
DNA was incubated with buffer A + buffer B in a 1:4 ratio. Each
experimental point was performed in duplicate. In optimization
experiments, PARP inhibitor ABT-888 (Selleckchem) was added
to the extract at a concentration of 5µM to test the effect of
inhibiting the post-incision phase of BER.
NER-specific reaction
For the NER-specific assay, the protein extract was enriched with
adenosine-5′-triphosphate at a final concentration of 2.5mM. A
30µL aliquot of extract was added to each minigel in the incuba-
tion chamber. Each extract was in parallel incubated for 30min
with UV-treated and non-treated TK6 cells (used for background
subtraction). UV substrate incubated with Endo V was used as
positive control and 1:4 buffer A + buffer B as negative control.
In optimization experiments, aphidicolin (DNA polymerase delta
inhibitor; Sigma-Aldrich) at a concentration of 2.5µMwas added
to the extract to test the effect of DNA resynthesis inhibition.
Single cell gel electrophoresis
After the incubation period, the protocol followed was the same
as previously described for the comet assay (Olive and Banath,
2006). In brief: slides were treated for 20min under alkaline
conditions (0.3M NaOH, 1mM EDTA, pH 12) to allow DNA
denaturation and subsequently electrophoresed for 20min at
1.3 V/cm. Washing followed, with PBS, then H2O and finally
ethanol, each for 10min. Slides were stained with SYBRGold
(Invitrogen) at the concentration recommended by the manu-
facturer in a bath at 4◦C with agitation. After 40min, SYBRGold
solution was removed and the slides rinsed twice with water and
left to dry at room temperature. On the day of analysis gels were
hydrated by adding a drop of water on top of each minigel and
covered with a coverslip. The comets were evaluated by visual
scoring performed exclusively by one person (Azqueta et al.,
2011). Comets were analyzed by a Nikon fluorescence micro-
scope using 5 classes of comets from class 0 (undamaged, no
discernible tail) to class 4 (almost all DNA in tail, insignificant
head). Hundred comets were selected at random for each sam-
ple (50 comets per duplicate gel), so the overall score from one
sample ranged from 0 to 400 arbitrary units. Final DNA repair
activity was calculated as the difference between scores for treated
substrate incubated with extract and non-treated substrate incu-
bated with extract. (Visual scoring was preferred only because of
technical problems with image analysis software at the time of
the study; however, scoring with computerized software is equally
recommended).
GENOTYPING
Single nucleotide polymorphisms (SNPs) were selected accord-
ing to their (i) location in a gene involved in a pre-incision
complex of BER or NER whose activity is detectable by DNA
repair assays, (ii) minor allelic frequency >5%, and (iii) pre-
dicted damaging or deleterious effect on protein function by
SIFT or PolyPhen algorithms (Xi et al., 2004). DNA was isolated
from total blood by the phenol-chloroform method. SNPs were
detected by TaqMan® SNP Genotyping Assays based on allele-
specific TaqMan® MGB probes plus PCR primers and analyzed
on Applied Biosystems 96-well real-time PCR instrumentation
(Life Technologies). Functional SNPs in BER genes were repre-
sented by OGG1 Ser326Cys (rs 1052133). Selected SNPs within
NER genes involved XPA G23A (rs 1800975), XPC Ala499Val
(rs 2228000) and Lys939Gln (rs 2228001), XPD Lys751Gln (rs
13181), XPG Asn1104His (rs 17655) and XPF Arg415Gln (rs
1800067).
www.frontiersin.org May 2014 | Volume 5 | Article 116 | 3
Slyskova et al. DNA repair in human biopsies
REVERSE TRANSCRIPTION qPCR
Tissue samples were homogenized in the MagNA Lyser
(Hoffmann-La Roche). AllPrep DNA/RNA mini kit (Qiagen)
was used to isolate nucleic acids. Total RNA was measured on
ASP-3700 Spectrophotometer (Avans-Biotechnology) for quan-
tity and OD260/280 ratio. RNA integrity number (RIN) was
checked using Agilent Bioanalyzer 2100, with RNA 6000 Nano
Assay (Agilent Technologies). cDNA was synthesized from 500
ng of RNA using a RevertAidTM First strand cDNA synthe-
sis kit (Thermo Scientific) using random hexamers and fol-
lowing manufacturer’s instructions. cDNA was diluted to 10
ng/µL and preamplified for 18 cycles on a CFX96 Real Time
PCR Instrument (Biorad) according to the manufacturer’s pro-
tocol. qPCR was performed using the high-throughput platform
BioMark™ HD System (Fluidigm). Ten µL of reaction mix con-
tained 1µL of 20× diluted preamplified cDNA, 2.5µL of Taqman
Universal Mastermix II without UNG (Life Technologies), 5µL
of primer/probe assays with Perfect ProbeTM (Primer Design) at a
final concentration of 300 nM, 2.5µL of 2×Assay loading reagent
and 0.25µL of 20× GE sample loading reagent (Fluidigm) and
1.25µL of water. Cycling conditions for qPCR were: 95◦C for
10min, 45 cycles of 95◦C for 15 s and 50◦C for 60 s. TOP1
and 18S rRNA were reference genes selected from a geNormTM
reference genes selection kit (Primer Design) by Normfinder algo-
rithm (GenEx Enterprise software). Data were collected from one
48 × 48 array. Data were normalized to reference genes, converted
to relative quantities and transformed to log2 scale.
STATISTICAL ANALYSIS
Statistical analysis was performed by SPSS Statistics 18 (IBM)
and by GenEx Enterprise (MultiD) softwares. The distribution of
investigated parameters was controlled by Kolmogorov–Smirnov
test. Expression data were logarithmically transformed to achieve
a normal distribution. Two-tailed T-test or ANOVA for differ-
ences between groups for normally distributed data was employed
and correlations determined by a Pearson’s test. When data were
not distributed accordingly to a Gaussian curve, non-parametric
tests of Kruskal–Wallis, Mann–Whitney or Spearman’s correla-
tion coefficient were used. All statistical tests were performed at
a 95% confidence level.
RESULTS AND DISCUSSION
OPTIMIZATION OF THE BER- AND NER-SPECIFIC ASSAYS
An advanced medium-throughput 12-minigel format
In order to be able to process a larger number of samples and to
suppress the effect of inter-experimental variability, we have uti-
lized the 12-minigel format that was introduced by Shaposhnikov
et al. (2010) and is demonstrated in Figure 1. The comparabil-
ity of the new 12-minigel approach (12minigels of 5µl agarose
per slide) with the conventional 2-gel format (2 large gels of 70µl
agarose per slide) was tested by Azqueta et al. (2012). Therefore,
we have directly optimized the BER- and NER-repair assays for a
12-minigel format, without any additional testing.
The inter-experimental variability given by the 12-minigel for-
mat was low, with the coefficient of variation between 7 indepen-
dent experiments being 7.7% for both BER and NER (calculated
from the negative and positive control, data not shown). This
suggests that only up to 8% of variability might be attributed
to inter-experimental variations. The 12-minigel format, with
its 6-times higher yield of analyzed samples per microscopic
slide, significantly increases the applicability of repair assays to
human epidemiological studies. Sixteen samples can be optimally
run for both assays in one experiment, using only 9 micro-
scopic slides and 9 incubation chambers (see scheme displayed
in Figure 1). This capacity is not limited by the dimensions of the
electrophoretic tank, as is usually the case with the 2-gel format.
Another advantage is that the new format requires considerably
lower numbers of substrate cells. Instead of ∼3000 substrate
cells per gel, the 12-minigel format requires only a tenth of this
quantity.
Precision of the assays
To test repeatability of the assays, we have measured 25 samples
in two independent experiments and compared the results. As
shown in Figure 2, the inter-experimental variation is negligible
and both assays are repeatable with high reliability (p ≤ 0.001).
The assays were subsequently tested for the ability to rec-
ognize protein extracts deficient in the incision step of repair.
For that purpose, extracts from OGG1- and XPG-deficient cells
were isolated and their activity compared with the extracts iso-
lated from cells of the same origin but expressing both genes.
Figure 3 presents observed results in comparison to positive
and negative controls, as described in detail in BER- and NER-
specific reaction sections. While protein extracts from wild-type
cells showed activity significantly higher than activity measured
for knock-out cells (BER: p = 0.007, NER: p = 0.019), the low
activity of knock-out cells was not different from the unspe-
cific activity of buffer only (BER: p = 0.44, NER: p = 0.39).
Both assays confirmed a sensitivity to distinguish biological
variability.
Dependence of protein extract activity on protein concentration
We prepared tissue extract dilutions in the range 0 to 18mg/mL
protein content and measured the corresponding activity.
Surprisingly, the relation between protein concentration and
activity of the extract was not (log-)linear (higher protein amount
corresponding with higher activity), but instead exhibited an
increase of incision activity reaching its maximum at a protein
concentration of 3mg/mL, followed by a drop of activity with
further increasing content of proteins (Figure 4). At the con-
centration point of 3 mg/mL the ratio between lesion-specific
activity and non-specific endonuclease activity of the extract was
the highest and in favor of the former. Another confounder
would be represented by the ratio between protein amount and
accessibility of DNA lesions. Too high protein concentration
leads to saturation of the reaction. However, protein concen-
tration optimal for the assays was shown to be tissue-specific,
as studied on animal tissues (Langie et al., 2010, 2011), and
therefore the concentration set by us is not generally applica-
ble. The optimal concentration should be tested by each user of
the assay on particular biological samples. Time of incubation
is also a variable that can be recommended, but anyway should
be pre-tested on each particular substrate DNA with specific
extracts.
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FIGURE 1 | Medium-throughput comet assay format and layout of
the experiment. (A) Device for 12-minigel format, (B) image of
comets, and (C) a schematic example of an experiment, using 16
different extracts, background control with buffer only (BC) and a
positive control with specific enzyme (PC). The experimental layout
with 9 microscope slides is applicable only if the same substrate
cell-type is used in each assay, so that the same non-treated cells
can be used for both.
FIGURE 2 | Inter-experimental variability. Comparison of tissue extract activities measured in two separate experiments (Spearman’s correlation coefficient).
Paired T -test p-values were 0.58 for BER (A) and 0.1 for NER (B).
Do intermediate SBs reflect the incision activity?
To test the postulate that SBs measured in the assays are gen-
erated specifically by the incision activity of the protein extract,
we have used specific agents to inhibit post-incision phase of the
repair processes. ABT-888 is a well-known inhibitor of the Poly-
(ADP)-ribose polymerase (PARP) and has therefore been used
in the BER assay. The post-incision NER phase was blocked by
aphidicolin (APC), inhibiting the function of polymerase delta.
On adding the specific inhibitors, all SBs generated by incision
activity are expected to remain “open.” As Figure 5 documents,
the tissue extracts correspond in 85–88% of their activities irre-
spective of the presence of the inhibitors. Thus, BER and NER
assays detect specifically the incision step of the whole repair
process, which is regarded the rate-limiting step (Collins, 1987;
Shivji et al., 1992). It involves proteins that are rather active
in the repair of DNA damage, unlike post-incision complexes
that take part also in the replication or transcription of DNA.
The extract is not able to perform the synthetic stages of repair,
unless deoxyribonucleotides, and ATP are provided (Collins et al.,
1994).
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FIGURE 3 | Testing the extracts from DNA repair gene knock-out cells.
Measurement of BER and NER activities in knock-out cells and wild-type
control cells of the same origin. For (A) BER assay extracts were isolated from
OGG1−/− and OGG1+/+ mice livers; negative control (NC) represents
incubationwith buffer only and positive control (PC) incubationwith Fpg. For (B)
NER assay extracts were isolated from XPG−/− and XPG+/+ hamster ovarian
cancer cells CHO AA8, and NC and PC represent incubation with buffer and
Endo V, respectively. Data represent means ± SD of duplicate measurements.
FIGURE 4 | Relationship between protein concentration of extract and its activity. Different protein concentrations of tissue extracts plotted against their
BER (A) and NER (B) activities. Each experimental point represents mean ± SD of duplicate measurements.
FIGURE 5 | Testing the inhibition of post-incision phase. Comparison of
BER (A) and NER (B) activities between extracts treated with inhibitors of
polymerization and the same extracts not suppressed for the polymerization
activity (Spearman’s correlation coefficient). ABT-888, inhibitor of
Poly-(ADP)-ribose polymerase; APC, aphidicolin - inhibitor of DNA polymerase
delta.
DNA REPAIR CAPACITY IN RELATION TO OTHER CELLULAR
BIOMARKERS
Genotype–phenotype interactions
Ro-induced oxidative damage is mainly represented by 8-oxoG.
There are several enzymes known to be specialized for this
particular lesion; however the 8-oxoguanine DNA glycosylase
(OGG1) is the primary enzyme recognizing and incising this
lesion. Among others, NEIL1 and NEIL2 have marginal activity in
repair of this lesion, NTH1 repairs free 8-oxoG and MUTYH rec-
ognizes adenine already mispaired with 8-oxoG. Therefore, BER
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activity, as measured in vitro in our assay toward Ro-induced
lesions, is mainly reflecting the activity of the BER glycosylase
OGG1. In contrast to BER, NER enzymes work in large complexes
and the minimal requirement for the incision comprises at least
20 proteins.
The majority of BER and NER genes are polymorphic in the
population, and over 50% of them have functionally relevant
amino acid changes. By applying SIFT or PolyPhen algorithms,
several SNPs are predicted to be possibly damaging, damaging,
or deleterious, by means of protein function (Xi et al., 2004)
and these in silico characterizations are also supported by a range
of epidemiological and in vitro studies. In this study, functional
SNPs in BER genes were represented by the commonly studied
OGG1 Ser326Cys, while NER genes were represented by XPA
G23A, XPC Ala499Val and Lys939Gln, XPD Lys751Gln, XPG
Asn1104His and XPF Arg415Gln. All of these potentially func-
tional SNPs were genotyped in the cohort of 68 individuals and
their effects on BER and NER activity of colorectal tissues were
studied. None of the studied SNPs showed any direct associa-
tion with DNA repair activity in either healthy or tumor tissues,
except for XPA 23A allele that was associated with lower BER
in tumor tissues only (Table 1). An association of XPA G23A
genotype with BER activity in PBMC was observed by Dusinska
et al. (2006), although in a relationship opposite to that found
by us. Conflicting findings were obtained from studies with Xpa-
deficient mice, where XPA seems not to play an important role in
oxidative DNA damage repair (Melis et al., 2013). We are aware of
low statistical power and risk of type 2 error due to the low num-
ber of individuals carrying variant alleles. Nonetheless, reports
on genetic variability in relation to DNA repair activity of target
tissue (i.e., tissue other than blood) were missing until now.
Is protein activity related to level of gene transcription?
We have measured the amount of OGG1 transcripts in paired
tumor-healthy human colorectal tissues and compared it with
the BER-related incision activity, which represents mainly OGG1
activity. The activity of the protein was completely indepen-
dent of the mRNA quantity, with Pearson’s correlation coefficient
close to 0 for both tumor and normal tissue (Figure 6). Lack
of a relationship between mRNA level and activity of the pro-
tein is not rare in the literature (Damia et al., 1998; Vogel
et al., 2000; Paz-Elizur et al., 2007; Stevens et al., 2008; Slyskova
et al., 2012a,b). On the contrary, there is growing evidence on
the important role of regulation of enzyme activity at post-
transcriptional and post-translational levels. OGG1 is a house-
keeping gene of constitutive expression independent of the cell
cycle (Dhenaut et al., 2000). It might be regulated via two CpG
islands located in the promoter region; however, this was not the
case in our samples since none of 88 samples exhibited C methy-
lation in OGG1 promoter (Slyskova et al., 2012b). OGG1 has
eight alternative isoforms/splicing variants of two major groups;
type 1 acts in the nucleus, and type 2 in the mitochondria
(Boiteux and Radicella, 2000). However, this would not serve as
Table 2 | Correlation of expression of 17 genes involved in NER
pre-incision complex with overall NER incision activity (Pearson’s
correlation coefficient).
Gene NER activity
Healthy tissue (N = 44) Tumor (N = 44)
R p-value R p-value
CCNH −0.146 0.35 −0.028 0.86
CDK7 −0.012 0.94 0.320 0.036
CSB −0.101 0.51 −0.039 0.80
DDB1 −0.158 0.31 −0.094 0.54
DDB2 −0.200 0.19 −0.183 0.23
ERCC1 −0.133 0.39 −0.146 0.35
LIG1 0.086 0.58 0.123 0.43
MNAT1 −0.125 0.42 −0.094 0.54
RAD23B −0.030 0.85 0.190 0.22
RPA1 −0.079 0.61 −0.05 0.75
RPA2 0.007 0.96 0.067 0.67
RPA3 −0.039 0.80 0.225 0.14
XPA −0.168 0.28 −0.246 0.11
XPB −0.055 0.73 −0.009 0.96
XPC −0.062 0.69 −0.004 0.98
XPD −0.164 0.29 −0.001 0.99
XPF −0.136 0.38 −0.091 0.56
Associations with p-value < 0.05 are shown in bold.
FIGURE 6 | Correlation between OGG1 expression and BER incision activity. Relative quantity of OGG1 transcripts measured in 44 paired healthy (A) and
tumor (B) tissue samples plotted against BER activity (Pearson’s correlation coefficient).
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an explanation of missing mRNA quantity/protein activity corre-
lation either, since all transcript variants have been covered in the
assay. Nevertheless, other mechanisms might regulate gene activ-
ity; for example 160 microRNAs identified up to now are able
to bind to OGG1 transcripts (http://bioinformatics.ekmd.huji.
ac.il/reptar/gene_report.php?species=human&id=12458). Above
all, two post-translational modifications—phosphorylation and
nitrosylation—modulate the final protein activity. Another
source of variability might be represented by protein–protein
interactions (Fan and Wilson, 2005).
The mRNA expression of the majority of proteins forming
the pre-incision complex of NER was also measured and plot-
ted against the overall NER activity. The expression level of none
of the 17 studied genes was significantly associated with the NER
incision activity, except forCDK7 protein involved in TFIIH com-
plex in the tumor tissue only (Table 2). DNA damage recognition
and incision is much more complex in NER as compared to BER.
In BER, usually only 1 or 2 proteins are able to recognize and
incise damage from DNA, while in NER, the whole complex of
many proteins is required for lesion removal. NER proteins work
in an interactive downstream manner and are known to be sub-
stantially regulated at a post-translational level, which makes the
lack of correlation of single gene expression and endpoint NER
incision activity understandable. According to our results and the
results of other research groups (Damia et al., 1998; Vogel et al.,
2000; Paz-Elizur et al., 2007; Stevens et al., 2008; Hanova et al.,
2011; Slyskova et al., 2012b), expression analysis of single genes
is not a sufficiently informative marker of activity of protein or
protein complexes.
CONCLUDING REMARKS
Analyzing DNA repair activity in target tissue might repre-
sent an important step toward individualized anti-cancer ther-
apy. Previously we have shown that activities of the BER and
NER pathways positively correlate between white blood cells and
healthy colon tissue, but not between blood cells and tumor
(Slyskova et al., 2012b). Therefore, methods for assessing func-
tionality of DNA repair in solid tissues are warranted. New
comet-based repair assays are reliable, simple, fast, and of low
cost. An advanced medium-throughput format is suitable for
large epidemiological studies. We have also shown that measur-
ing DNA repair activity is not easily replaceable by a genomic or
transcriptomic approach, but should be applied with the latter
techniques in a complementary manner.
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